MeMed
PrivateLast Round
VC Round
Jan 10, 2022
Total Funding Raised
$98.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MeMed is a healthcare technology company that develops immuno-personalized diagnostic devices to rapidly identify bacterial and viral infections by analyzing patients' immune responses, thereby assisting physicians in making informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MeMed Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
MeMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 10, 2022 | ||||
| Grant | Nov 13, 2019 | ||||
| Series C | Sep 20, 2018 | ||||
| Grant | Feb 6, 2018 | ||||
| Grant | Apr 19, 2017 | ||||
Grant | Sep 18, 2015 |
Key People
Founding team and executive leadership
MeMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series C, VC Round |
| European Innovation Council | Grant |
| Union Tech Ventures | VC Round |
| European Commission (Horizon Europe) | Grant |
| Clal Insurance | Series C |
| S28 Capital | Series C |
| Touchwood Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Developing a next-generation AIVD product.
- Mar 1, 2026
Diagnostic technology receives FDA clearance and is in use.
MeMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MeMed's valuation, stock price, and market status.